Production of Molecular Based Point-of-care Protocol for SARS-CoV-2 Detection Among Humans, and Comprehensive Atlas of Possible Coronavirus Immune Response Differences Between Humans, and Non-Human Primates

Principal investigator: Pacifique Ndishimye
Check PI profile

Investigators

Pacifique Ndishimye, Jean Claude Udahemuka, Julius Nziza, Kelvin David, Emile Yvan, Ladislas Nshimiyimana, Valentine Dushimiyimana, Clarisse Musanabaganwa, Etienne Karita, Jean Bizimana, Julien Nyombayire, Richard Muvunyi, Phiyani Lebea, Natasha Beeton, Lindiwe Thete, Sharon Maremagae, Fathiah Zakham, Olli Vapalahti, Thomas Strandin, Tarja Sironen, Sabin Nsanzimana






Study information

  • Research Area: COVID-19
  • Research type: Diagnostic study
  • Start date: Dec 01, 2020
  • End date: Dec 31, 2021

Study aim of the objectives

The main goal of this study is twofold; first, to produce a molecular based point-of-care protocol for SARS-CoV-2 detection. Secondly, to test the veracity of covid-19 in non-human primates

Study setting/Area (Location)

Volcano National Park

Implementing institution

RBC with consortium with University of Helsinki and TokaBio company, Gorilla Doctors and University of Rwanda

Department/Division

RIDS

Impact on Policy

Our final product is envisaged to present a combination of technologies (extraction protocol, detection instrument and result reporting software) that is suited for Covid-19 contact tracing and instan

Study implementation progress

Related research

Login
Support